Guse Kyle Insider Trades

Insider Trading History

Track insider trading activity for Guse Kyle. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Plus Therapeutics
Plus Therapeutics PSTV
Director
Holding Value $20k 3,686 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.5k 7,372 shares
$5.76
$5.42
Plus Therapeutics
Plus Therapeutics PSTV
Director
Holding Value $1.61M 297,794 shares
Last Trade
Aug 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$193k 337,794 shares
$0.57
$5.42
Atossa Therapeutics
Atossa Therapeutics ATOS
Cfo, Gen Counsel And Secretary
Holding Value $2.62M 557,900 shares
Last Trade
Mar 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$402k 557,900 shares
$0.72
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Cfo, Gen Counsel And Secretary
Holding Value $3.51M 746,667 shares
Last Trade
Feb 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$933k 746,667 shares
$1.25
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Cfo, Gen Counsel And Secretary
Holding Value $4M 850,000 shares
Last Trade
May 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37M 850,000 shares
$43.50
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Cfo, Gen Counsel And Secretary
Holding Value $1.86M 395,000 shares
Last Trade
Apr 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.1M 590,000 shares
$22.20
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Cfo, Gen Counsel And Secretary
Holding Value $0 0 shares
Last Trade
Jan 13, 2019 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$14.3M 700,000 shares
$20.40
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Cfo, Gen Counsel And Secretary
Holding Value $3.76M 800,000 shares
Last Trade
Jan 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.3M 800,000 shares
$20.40
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Cfo, Gen Counsel And Secretary
Holding Value $3.29M 700,000 shares
Last Trade
Jun 27, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25M 700,000 shares
$35.70
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Cfo, Gen Counsel And Secretary
Holding Value $10.7k 2,272 shares
Last Trade
May 30, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$110k 2,280 shares
$48.30
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Cfo, Gen Counsel And Secretary
Holding Value $47k 10,000 shares
Last Trade
Nov 15, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$612k 10,000 shares
$61.20
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Cfo, Gen Counsel And Secretary
Holding Value $3.01M 640,667 shares
Last Trade
May 24, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.9M 495,333 shares
$84.60
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
Cfo, Gen Counsel And Secretary
Holding Value $5.12M 1,090,000 shares
Last Trade
May 18, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$765M 1,090,000 shares
$702.00
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
See Remarks
Holding Value $893k 190,000 shares
Last Trade
Mar 16, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$964M 190,000 shares
$5,076.00
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
CFO & General Counsel
Holding Value $940k 200,000 shares
Last Trade
May 06, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$659M 200,000 shares
$3,294.00
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
CFO & General Counsel
Holding Value $658k 140,000 shares
Last Trade
Jan 08, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$832M 140,000 shares
$5,940.00
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
CFO & General Counsel
Holding Value $282k 60,000 shares
Last Trade
Jun 04, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$698M 60,000 shares
$11,637.00
$4.70
Atossa Therapeutics
Atossa Therapeutics ATOS
CFO & General Counsel
Holding Value $0 0 shares
Last Trade
Jan 04, 2013 Sale
$5.54B 500,000 shares
$11,070.00
$4.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up